Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
Ro 32-0432
PKC
PKC
10473.142
uM
inf
inf
1.0380 1.0380 0.0000 -0.0178
-0.2214
1.0815
CAMA-1
HR+
Luminal
SB-3CT
MMP2/9
MMP
12070.144
uM
inf
inf
0.8317 0.8317 0.0000 0.0762
0.1224
1.1742
CAMA-1
HR+
Luminal
Selumetinib
MEK
MAPK
10755.146
uM
inf
inf
0.7223 0.7223 0.0000 0.1526
0.4825
0.8035
CAMA-1
HR+
Luminal
Selumetinib
MEK
MAPK
12070.155
uM
inf
0.19248
0.8618 0.8946 1.6293 0.0419
0.7660
1.1729
CAMA-1
HR+
Luminal
Sigma A6730
AKT
AKT
10473.141
uM
5.97870
15.75880
-0.6868 -1.0000 1.1335 0.3294
0.9551
1.2804
CAMA-1
HR+
Luminal
Sigma A6730
AKT
AKT
10755.153
uM
10.12190
11.78250
-0.5684 -0.5687 5.0000 0.2778
0.9603
0.7471
CAMA-1
HR+
Luminal
Sigma A6730
AKT
AKT
12070.158
uM
2.60090
7.86290
-0.8870 -1.0000 0.9931 0.3840
0.9790
1.1252
CAMA-1
HR+
Luminal
Sirolimus
MTOR
MTOR
7805.068
uM
0.00849
0.00815
-0.2105 0.0163 0.8149 0.7353
0.9263
0.8633
CAMA-1
HR+
Luminal
Sirolimus
MTOR
MTOR
5911.068
uM
0.01408
0.01156
0.0336 0.1058 1.2029 0.6546
0.9810
0.9873
CAMA-1
HR+
Luminal
Sirolimus
MTOR
MTOR
5912.069
uM
0.03669
0.03299
-0.0122 0.0322 0.6262 0.5126
0.9818
0.9582
CAMA-1
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5912.084
uM
766.13020
1000.00000
0.4668 -0.0794 0.5535 0.1352
0.8112
1.0966
CAMA-1
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5911.084
uM
20.33960
33.53810
-0.7616 -0.7737 1.8697 0.4881
0.9961
1.0262
CAMA-1
HR+
Luminal
Sulindac sulfide
COX1/2
COX
10473.136
uM
inf
inf
0.9598 0.9598 0.0000 0.0241
0.0000
1.3186
CAMA-1
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5912.067
uM
8.33920
10.91890
-0.9743 -0.9761 4.0165 0.4450
0.9947
1.1725
CAMA-1
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5911.067
uM
7.6070
9.77620
-0.9909 -0.9918 4.3572 0.4414
0.9968
1.0037
CAMA-1
HR+
Luminal
Taxol
TUBB
TUBB
9210.002
uM
0.01086
0.01202
-0.3518 -0.3303 4.9965 0.8093
0.9977
0.8958
CAMA-1
HR+
Luminal
TCS 2312
CHK1
CHK
10473.14
uM
1.05240
1.88470
-0.6353 -0.6914 1.4900 0.4421
0.9807
1.3126
CAMA-1
HR+
Luminal
TCS 2312
CHK1
CHK
10755.152
uM
0.66362
1.51340
-0.9273 -0.9919 1.3261 0.5276
0.9879
0.5859
CAMA-1
HR+
Luminal
TCS 2312
CHK1
CHK
12070.159
uM
0.54336
0.97998
-0.9595 -0.9754 1.8348 0.5187
0.9981
0.9846
CAMA-1
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
12070.135
uM
inf
inf
0.7536 0.7536 0.0000 0.1198
0.1619
1.2457
CAMA-1
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10473.135
uM
inf
inf
0.5662 0.5662 0.0000 0.0922
0.3589
1.1592
CAMA-1
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10755.148
uM
inf
inf
0.5279 0.5279 0.0000 0.2240
0.4039
0.6379
CAMA-1
HR+
Luminal
Temsirolimus
MTOR
MTOR
12070.144
uM
0.04893
1.40230
-0.9418 -1.0000 0.3274 0.7534
0.9098
1.1742
CAMA-1
HR+
Luminal
Topotecan
TOP1
TOP
9210.121
uM
0.39996
5.10
-0.6908 -1.0000 0.4316 0.5442
0.9511
0.8970
CAMA-1
HR+
Luminal
Torkinib
15348.211
uM
0.00176
0.01477
-0.8919 -0.9141 0.4883 1.1876
0.9886
0.7490